Most sold healthcare stocks in Q2 2024
See which Healthcare stocks institutional investors trimmed or exited the most in Q2 2024, measured as net reductions in reported share positions from Q1 2024 into Q2 2024. Notable reductions at the top of this list include TELADOC HEALTH INC (TDOC), THE CIGNA GROUP (CI), EXACT SCIENCES CORP (EXAS), DANAHER CORP (DHR). These rankings are based on SEC 13F filings from the investors we track.
Explore more:
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| TDOC | TELADOC HEALTH INC | -8,617,134 | -$115.55M | 0 | 0 | 2 | 0 | 2 |
| CI | THE CIGNA GROUP | -4,196,611 | -$1.92B | 0 | 2 | 4 | 1 | 7 |
| EXAS | EXACT SCIENCES CORP | -3,385,741 | -$189.62M | 0 | 1 | 2 | 0 | 3 |
| DHR | DANAHER CORP | -3,310,893 | -$826.02M | 0 | 3 | 3 | 1 | 11 |
| VERV | VERVE THERAPEUTICS INC | -2,829,240 | -$63.58M | 0 | 1 | 1 | 0 | 2 |
| VSTM | VERASTEM INC | -2,481,357 | -$28.98M | 0 | 0 | 0 | 2 | 0 |
| NVO | NOVO-NORDISK A/S-SPONS ADR | -1,939,984 | $1.39B | 0 | 2 | 2 | 0 | 6 |
| SGRY | SURGERY PARTNERS INC | -1,933,236 | -$76.94M | 0 | 0 | 2 | 0 | 2 |
| EWTX | EDGEWISE THERAPEUTICS INC | -1,903,400 | -$34.23M | 0 | 0 | 1 | 1 | 1 |
| TMO | THERMO FISHER SCIENTIFIC INC | -1,749,589 | -$1.21B | 1 | 3 | 6 | 2 | 10 |
| BSX | BOSTON SCIENTIFIC CORP | -1,721,273 | -$116.64M | 0 | 2 | 1 | 1 | 4 |
| CERS | CERUS CORP | -1,704,812 | -$5.33M | 0 | 0 | 2 | 0 | 2 |
| WBA | WALGREENS BOOTS ALLIANCE INC | -1,634,755 | -$15.61M | 0 | 1 | 1 | 1 | 2 |
| GEHC | GE HEALTHCARE TECHNOLOGY | -1,442,955 | -$453.89M | 0 | 3 | 2 | 1 | 8 |
| BLUE | BLUEBIRD BIO INC | -1,393,696 | $766.80K | 0 | 1 | 1 | 0 | 2 |
| CYH | COMMUNITY HEALTH SYSTEMS INC | -1,373,621 | -$4.00M | 0 | 1 | 0 | 1 | 1 |
| NKTR | NEKTAR THERAPEUTICS | -1,306,848 | $4.10M | 0 | 0 | 1 | 0 | 1 |
| ALGN | ALIGN TECHNOLOGY INC | -1,275,014 | -$573.85M | 1 | 2 | 4 | 1 | 8 |
| AGL | AGILON HEALTH INC | -1,261,022 | -$5.94M | 0 | 0 | 1 | 2 | 1 |
| OPK | OPKO HEALTH INC | -1,093,453 | $354.27K | 0 | 0 | 1 | 0 | 1 |
| ARAY | ACCURAY INC | -962,008 | $2.72M | 0 | 1 | 0 | 1 | 1 |
| AQST | AQUESTIVE THERAPEUTICS INC | -879,600 | $1.28M | 0 | 0 | 1 | 0 | 1 |
| TWST | TWIST BIOSCIENCE CORP | -850,210 | $63.81M | 0 | 0 | 1 | 1 | 1 |
| EDIT | EDITAS MEDICINE INC | -799,989 | $453.00K | 0 | 0 | 1 | 0 | 1 |
| QIPT | QUIPT HOME MEDICAL CORP | -776,930 | -$2.35M | 0 | 0 | 1 | 1 | 1 |
| BHC | BAUSCH HEALTH COS INC | -760,600 | -$139.15M | 0 | 0 | 1 | 2 | 3 |
| ACRS | ACLARIS THERAPEUTICS INC | -751,200 | $1.01M | 0 | 0 | 1 | 0 | 1 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | -726,707 | -$120.74M | 0 | 1 | 3 | 1 | 4 |
| EBS | EMERGENT BIOSOLUTIONS INC | -717,553 | $1.18M | 0 | 0 | 1 | 0 | 1 |
| ESPR | ESPERION THERAPEUTICS INC | -694,600 | $3.15M | 0 | 0 | 1 | 0 | 1 |
| AZN | ASTRAZENECA PLC-SPONS ADR | -681,654 | $7.66M | 0 | 2 | 3 | 0 | 5 |
| TVTX | TRAVERE THERAPEUTICS INC | -658,200 | $18.09M | 0 | 0 | 1 | 0 | 1 |
| SNY | SANOFI-ADR | -645,842 | -$37.65M | 1 | 3 | 1 | 0 | 5 |
| INCY | INCYTE CORP | -634,536 | $363.20M | 0 | 1 | 3 | 0 | 4 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | -630,200 | $5.93M | 0 | 0 | 1 | 0 | 1 |
| ME | 23ANDME HOLDING CO -CLASS A | -621,382 | $1.65M | 0 | 0 | 1 | 0 | 1 |
| LAB | STANDARD BIOTOOLS INC | -612,349 | -$66.26M | 0 | 0 | 2 | 0 | 3 |
| NVS | NOVARTIS AG-SPONSORED ADR | -591,498 | $372.80M | 0 | 2 | 4 | 0 | 6 |
| KZR | KEZAR LIFE SCIENCES INC | -559,600 | $465.88K | 0 | 0 | 1 | 0 | 1 |
| BEAM | BEAM THERAPEUTICS INC | -556,035 | -$91.66M | 0 | 0 | 1 | 0 | 1 |
| TGTX | TG THERAPEUTICS INC | -531,229 | $5.49M | 0 | 0 | 1 | 0 | 1 |
| HCAT | HEALTH CATALYST INC | -502,200 | -$3.30M | 0 | 0 | 1 | 1 | 1 |
| MCK | MCKESSON CORP | -481,854 | -$218.78M | 0 | 1 | 4 | 1 | 6 |
| PINC | PREMIER INC-CLASS A | -481,264 | $1.62M | 0 | 0 | 1 | 0 | 1 |
| IMUX | IMMUNIC INC | -456,184 | $322.12K | 0 | 0 | 1 | 0 | 1 |
| OM | OUTSET MEDICAL INC | -452,388 | -$1.00K | 0 | 0 | 0 | 1 | 0 |
| ISRG | INTUITIVE SURGICAL INC | -444,929 | -$148.83M | 1 | 2 | 3 | 0 | 6 |
| SEER | SEER INC | -439,530 | $837.30K | 0 | 0 | 2 | 0 | 2 |
| ZTS | ZOETIS INC | -434,328 | $109.46M | 0 | 4 | 5 | 1 | 10 |
| HRTX | HERON THERAPEUTICS INC | -412,686 | $6.97M | 0 | 0 | 1 | 0 | 1 |
Frequently asked questions about Most sold healthcare stocks in Q2 2024
What are the most sold Healthcare stocks in Q2 2024?
The most sold healthcare stocks in Q2 2024 are those with the largest decrease in reported share counts across tracked institutional investors compared to Q1 2024, based on SEC 13F filings.
Which healthcare stocks did institutional investors trimmed or exited the most in Q2 2024?
Among the managers we track, net reductions were largest in companies such as TELADOC HEALTH INC (TDOC), THE CIGNA GROUP (CI), EXACT SCIENCES CORP (EXAS), based on aggregated 13F data.
How is institutional selling calculated?
Selling is calculated by summing the net decrease in shares reported by tracked investors between two consecutive quarterly 13F snapshots (compared to Q1 2024).
Does this include all institutional owners?
These rankings are based on a subset of tracked institutional investors who file SEC 13F reports. While not exhaustive, the dataset includes many of the largest and most influential funds.
Are these trades real-time?
No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.